|
|
.
See Category: Injury, poisoning and certain other consequences of external causes
See Header: Anterior displaced Type II dens fracture
ICD-10 (CM) Code and Descriptor
|
S12.110K |
Anterior displaced Type II dens fracture, subsequent encounter for fracture with nonunion
|
S12110K utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 53.33%
|
18.77%
|
8.15%
|
6.67%
|
2.22%
|
3.70%
|
1.23%
|
0.99%
|
0.74%
|
0.49%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for S12.110K*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
72125
|
CT NECK SPINE W/O DYE |
75
|
75
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
62
|
119
|
|
72040
|
X-RAY EXAM NECK SPINE 2-3 VW |
60
|
60
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
48
|
48
|
|
97110
|
THERAPEUTIC EXERCISES |
36
|
71
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
32
|
34
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
28
|
28
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
26
|
117
|
|
J3010
|
FENTANYL CITRATE INJECTION |
21
|
42
|
|
72050
|
X-RAY EXAM NECK SPINE 4/5VWS |
20
|
20
|
|
80053
|
COMPREHEN METABOLIC PANEL |
19
|
19
|
|
97530
|
THERAPEUTIC ACTIVITIES |
19
|
23
|
|
80048
|
METABOLIC PANEL TOTAL CA |
19
|
19
|
|
J2405
|
ONDANSETRON HCL INJECTION |
19
|
80
|
|
70450
|
CT HEAD/BRAIN W/O DYE |
18
|
18
|
|
97112
|
NEUROMUSCULAR REEDUCATION |
18
|
21
|
|
J1170
|
HYDROMORPHONE INJECTION |
16
|
28
|
|
97535
|
SELF CARE MNGMENT TRAINING |
15
|
26
|
|
G1004
|
CDSM NDSC |
14
|
15
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
14
|
1,170
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
S12.110K related to the following DRG Codes:
564-566
|
